Reflux esophagitis is visible inflammation and damage to the lining of the esophagus caused by stomach contents washing back up repeatedly. Unlike broader gastroesophageal reflux disease (GERD), which can exist without any visible injury, reflux esophagitis means an endoscope has caught actual breaks, erosions, or ulceration in the tissue. The condition affects a substantial share of people who undergo upper endoscopy for reflux symptoms, and its severity ranges from a few tiny mucosal breaks to circumferential ulceration that can narrow the swallowing passage over time.
What Causes the Damage
Stomach acid gets most of the blame, but the actual tissue injury is a team effort. Acid alone can erode the esophageal lining, yet the combination of acid with pepsin and bile acids is far more destructive than any single agent. Animal and human studies consistently show that conjugated bile acids working alongside acid and pepsin have the greatest potential to damage the esophageal mucosa.1PubMed. Review article: role of pepsin and bile in gastro-oesophageal reflux disease Unconjugated bile acids can also cause harm even at a more neutral pH, which helps explain why some people develop esophagitis despite having relatively modest acid exposure.2PubMed. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease
The reflux itself is driven by temporary relaxations of the lower esophageal sphincter, the muscular ring at the bottom of the esophagus that normally keeps stomach contents where they belong. These brief relaxations are a normal part of digestion, but research shows that once acid starts reaching the esophagus, it can trigger even more of these relaxations. Acid appears to stimulate sensory nerves in the esophageal lining, which feeds back through the nervous system to open the sphincter more often, creating a self-reinforcing cycle.3PubMed Central. Acid Infusion into the Esophagus Increases the Number of Meal-Induced Transient Lower Esophageal Sphincter Relaxations (TLESRs) in Healthy Volunteers
At the cellular level, the esophageal lining in people with GERD shows weakened barrier function. The tight junctions that hold epithelial cells together, particularly proteins called claudin-1 and claudin-4, are reduced compared to healthy tissue.4PubMed. Esophageal barrier function and tight junction expression in healthy subjects and patients with gastroesophageal reflux disease This means the lining is more permeable and less able to defend itself against the next wave of reflux, which compounds the problem over time.
Symptoms That Go Beyond Heartburn
The classic symptoms are burning behind the breastbone and acid regurgitation, but reflux esophagitis produces a wider roster of complaints than most people expect. A study comparing symptom patterns across different severities of erosive esophagitis found that people with milder erosions (grades A and B on the standard scale) actually reported more frequent epigastric pain, fullness, throat clearing, and even dysphagia than those with more severe erosions.5PubMed Central. The Frequencies of Gastroesophageal and Extragastroesophageal Symptoms in Patients with Mild Erosive Esophagitis, Severe Erosive Esophagitis, and Barrett’s Esophagus in Taiwan That counterintuitive finding suggests the severity of mucosal damage and the intensity of symptoms do not track neatly together.
Reflux can also generate problems outside the esophagus entirely. A variety of ear, nose, throat, and lung conditions are now recognized as extraesophageal manifestations of GERD. These include asthma, chronic cough, laryngeal inflammation, chronic sinusitis, excessive throat mucus, and even middle-ear infections.6PubMed Central. Extraoesophageal manifestations of gastro-oesophageal reflux If you have been chasing a persistent cough or hoarse voice without a clear respiratory explanation, reflux is worth investigating.
How Doctors Grade It
When an endoscopy reveals erosive esophagitis, doctors classify what they see using the Los Angeles (LA) classification system. It runs from grade A (one or more mucosal breaks no longer than five millimeters) through grade D (mucosal breaks covering at least three-quarters of the esophageal circumference). The practical difference between grades matters more than you might think.
Recent research using advanced pH-impedance testing has shown that LA grade B esophagitis reliably signals true pathological reflux disease, with all grade B patients meeting objective criteria for GERD. Grade A, by contrast, is far less definitive: only about 18% of patients with grade A erosions had objective evidence of GERD by the same testing standards.7American Journal of Gastroenterology. Ambulatory pH-Impedance Findings Confirm That Grade B Esophagitis Provides Objective Diagnosis of Gastroesophageal Reflux Disease This is one reason some guidelines now treat grade B and above as conclusive for GERD, while grade A may need additional testing to confirm.
The histological picture adds another layer. Patients with LA grade A esophagitis rarely show true erosive or ulcerative changes under the microscope, while roughly a fifth of those with grades C and D do.8PubMed. The Los Angeles and Savary-Miller systems for grading esophagitis: utilization and correlation with histology The endoscopic appearance and the tissue-level reality do not always match up perfectly, which is part of why diagnosing and managing reflux esophagitis is less straightforward than it seems.
Distinguishing It From Eosinophilic Esophagitis
One condition that can look similar on endoscopy is eosinophilic esophagitis, an immune-driven disorder where white blood cells called eosinophils pile up in the esophageal lining. Both can produce dysphagia and both can show inflammation, but the underlying causes and treatments are different. Biopsy is the key distinguishing tool: eosinophil counts are dramatically higher in eosinophilic esophagitis than in reflux-driven disease, and certain secondary tissue changes are more extensive as well.9PubMed. Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material This distinction matters because eosinophilic esophagitis responds to dietary modification and specific anti-inflammatory medications rather than standard acid suppression.
Acid Reflux Is Not Always Acid
A common misconception is that every reflux episode is a surge of stomach acid. Ambulatory monitoring in GERD patients and healthy controls shows that roughly a third of all reflux events are nonacid, meaning they involve liquid, bile, or gas without a significant pH drop. People with erosive esophagitis do have more acid reflux episodes than healthy individuals, and a higher proportion of their reflux events are acidic, but the nonacid fraction is still substantial in both groups.10PubMed. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings Most reflux events also involve a mix of gas and liquid, with gas preceding the liquid bolus in a large majority of episodes. This is why some people still have symptoms even on strong acid-suppressing medication: the reflux itself has not stopped, only its acidity has changed.
Proton Pump Inhibitors and What Comes After Them
Proton pump inhibitors (PPIs) like omeprazole, lansoprazole, and esomeprazole remain the backbone of treatment. They suppress acid production effectively and heal most erosive esophagitis within eight weeks. Among available PPIs, esomeprazole has a modest statistical edge in healing rates over older PPIs across all-comers, though the real-world difference is small for mild disease and more meaningful for severe disease.11PubMed. Esomeprazole versus other proton pump inhibitors in erosive esophagitis: a meta-analysis of randomized clinical trials
A newer class of drug, the potassium-competitive acid blocker vonoprazan, has shown clear advantages where PPIs struggle most. In a major trial, vonoprazan healed about 93% of erosive esophagitis compared to about 85% for lansoprazole. The gap widened sharply for severe disease (LA grades C and D), where vonoprazan healed about 92% versus 72% for the PPI.12Gastroenterology. Potassium-Competitive Acid Blocker Suppression of Gastric Acid in Erosive Esophagitis: Is Stronger and Longer Better? In maintenance therapy, the advantage persisted: roughly 77% of severe-disease patients stayed healed on vonoprazan versus about 62% on lansoprazole.13Gastroenterology. Vonoprazan, a Potassium-Competitive Acid Blocker, Is Superior to Lansoprazole for Managing Erosive Esophagitis For people whose severe esophagitis keeps relapsing on PPIs, vonoprazan represents a genuine step forward.
Concerns About Long-Term Acid Suppression
Many people with reflux esophagitis end up taking PPIs for years, especially when the condition returns as soon as they stop. This has raised questions about long-term safety. Observational studies and meta-analyses have linked prolonged PPI use with a range of potential adverse effects, including kidney problems, bone fractures, certain infections like C. difficile, low magnesium, vitamin B12 deficiency, and possible associations with dementia and cardiovascular events.14PubMed Central. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors The word “association” is doing heavy lifting here: most of these links come from observational data, where the sicker patients who take PPIs for years also carry other risk factors. Randomized trials have generally been more reassuring, but the uncertainty remains real enough that gastroenterologists increasingly recommend using the lowest effective dose and periodically reassessing whether a PPI is still needed.15PubMed Central. Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle
When Surgery Becomes the Better Option
For people who cannot tolerate long-term medication, who have persistent symptoms despite maximal drug therapy, or who have large-volume reflux with extraesophageal complications, surgery is a well-established alternative. Fundoplication, where the upper part of the stomach is wrapped around the lower esophagus to reinforce the sphincter, has been performed for decades. In one head-to-head comparison, patients who had laparoscopic fundoplication were far more likely to get off PPIs entirely (about 44%) compared to those who continued medication alone (about 7%), and they reported better quality of life scores.16PubMed Central. Nissen fundoplication vs proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale
A newer device-based option is magnetic sphincter augmentation, where a ring of magnetic beads is placed around the lower esophageal sphincter. Long-term data out to six to twelve years show that about 89% of patients met criteria for favorable outcomes, and over 90% reported satisfaction with the procedure. About three-quarters were free of bothersome esophageal symptoms at the latest follow-up. The trade-offs include a roughly 2.4% rate of needing dilation for persistent swallowing difficulty and about a 9% rate of requiring device removal over the full study period.17Scientific Reports. Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease Patients with severe disease going in were somewhat less likely to come off PPIs entirely compared to those with milder disease, but both groups showed similar improvements in quality-of-life scores and similar rates of esophagitis resolution after surgery.18PubMed. Efficacy of Magnetic Sphincter Augmentation Across the Spectrum of GERD Disease Severity
Obesity, Sleep Position, and Other Lifestyle Factors
Abdominal obesity is one of the strongest modifiable risk factors for reflux esophagitis. A systematic review and meta-analysis found that abdominal obesity raised the risk of reflux esophagitis by about 50%, and the risk climbed steadily as waist circumference increased, with an accelerating trend once it crossed roughly 87 centimeters.19PubMed. Abdominal obesity increases the risk of reflux esophagitis: a systematic review and meta-analysis The mechanism is straightforward: excess abdominal fat increases pressure inside the abdomen, which pushes against the stomach and forces contents upward.20PubMed Central. Obesity & GERD Weight loss in this context is not just general health advice; it directly addresses one of the physical forces driving the disease.
How you sleep also matters. A systematic review found that raising the head of the bed improved both reflux symptoms and objective pH measurements in most included studies.21PubMed Central. Head of bed elevation to relieve gastroesophageal reflux symptoms: a systematic review Sleeping on your left side is another evidence-backed strategy: because of the stomach’s anatomy, lying on the left keeps the gastroesophageal junction above the pool of gastric contents, while lying on the right submerges it. A randomized trial using a positioning device confirmed that left-side sleeping produced significantly less acid exposure in the esophagus than right-side, supine, or flat sleeping positions.22Journal of Clinical Gastroenterology. A Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: A Randomized Controlled Trial
What Happens If Esophagitis Goes Unchecked
Left untreated or inadequately treated, chronic reflux esophagitis can progress to complications that are harder to reverse. Peptic strictures, where scar tissue narrows the esophageal channel, develop especially in elderly patients and those with long-standing, poorly controlled reflux.23PubMed. Peptic strictures of the esophagus These typically cause progressive difficulty swallowing and require endoscopic dilation, sometimes repeatedly, along with ongoing acid suppression to prevent recurrence.
The more concerning long-term risk is Barrett’s esophagus, where the normal squamous lining of the lower esophagus is replaced by a type of columnar tissue resembling the intestinal lining. This change, driven by chronic exposure to both gastric and duodenal refluxate, represents a precursor state that is associated with the development of esophageal adenocarcinoma. The progression from reflux esophagitis to Barrett’s to cancer is not inevitable and happens in a small minority, but it is the reason doctors recommend surveillance endoscopy for patients with long-standing severe reflux disease.
Stress and Esophageal Sensitivity
Anyone who has noticed their heartburn flare during stressful periods is picking up on a real phenomenon. Research shows that stress heightens the esophagus’s sensitivity to acid, so the same amount of reflux feels worse. GERD patients exposed to acute stress reported increased heartburn during controlled acid exposure to the esophagus, and even disrupted sleep has been shown to produce similar hypersensitivity.24Journal of Neurogastroenterology and Motility. Can Acute Stress Cause Esophageal Hypersensitivity in Healthy Individuals?
A large population-based study in Sri Lanka found a clear dose-response relationship between perceived stress levels and GERD symptom scores. People with moderate to high stress had significantly more GERD-related symptoms and a wider variety of them compared to those with low stress.25PubMed Central. The association between symptoms of gastroesophageal reflux disease and perceived stress: A countrywide study of Sri Lanka This does not mean stress causes erosive esophagitis on its own, but it does mean that stress management can be a legitimate component of symptom control, not just a feel-good add-on.
Reflux Esophagitis During Pregnancy
Heartburn during pregnancy is so common it is practically a given, and the cause is primarily hormonal rather than mechanical. Even in early pregnancy, before the uterus is large enough to exert meaningful pressure, the lower esophageal sphincter’s ability to respond to stimulation is already blunted.26PubMed. Altered lower esophageal sphincter function during early pregnancy Progesterone, with estrogen acting as a primer, relaxes smooth muscle throughout the gastrointestinal tract, which reduces sphincter tone and slows esophageal motility.27PubMed. Gastrointestinal motility disorders during pregnancy Laboratory research has shown that estradiol directly relaxes lower esophageal sphincter muscle in a dose-dependent manner, working through a specific receptor present in the sphincter tissue.28PubMed. Estradiol mediates relaxation of porcine lower esophageal sphincter Treatment options during pregnancy are more limited because of fetal safety concerns, making lifestyle measures like head-of-bed elevation and left-side sleeping especially important.
Alginate Rafts and Over-the-Counter Options
For people looking for something beyond simple antacids but short of prescription acid suppression, alginate-based products occupy an interesting middle ground. These formulations react with stomach acid to create a buoyant gel “raft” that floats on top of the stomach contents, physically blocking reflux. The raft specifically targets the so-called acid pocket, a layer of unbuffered acid that sits on top of a meal near the gastroesophageal junction. Imaging studies with radiolabeled alginate have shown that these products settle directly on the acid pocket, reducing acid reflux episodes from roughly fifteen to about four and quadrupling the time before the first reflux event occurs after a meal. Alginate products are not powerful enough to heal established erosive esophagitis on their own, but they can be useful as adjuncts to PPIs or for people with mild, intermittent symptoms who want to avoid daily medication.
The Esophageal Microbiome in Reflux Disease
A newer and still-evolving area of research is the relationship between reflux esophagitis and the bacterial communities living in the esophagus. In healthy people, the esophagus and the stomach harbor distinct microbial populations, but in people with reflux esophagitis, this regional distinction breaks down. The microbial profiles across the upper, middle, and lower esophagus and the gastric fundus become strikingly similar, suggesting that chronic reflux homogenizes the microbial landscape of the upper digestive tract.29PubMed. Segmental analysis of esophageal and gastric fundus microbiome diversity in reflux esophagitis
The shift is not just about distribution but composition. In reflux esophagitis, there appears to be a broader transition from a community dominated by gram-positive bacteria toward more gram-negative species, which raises the possibility that microbial changes contribute to the inflammatory process rather than simply resulting from it.30PubMed Central. Microbiome in reflux disorders and esophageal adenocarcinoma The genus Prevotella has been flagged as a potential marker for reflux esophagitis in some studies, though findings are inconsistent. One study found Prevotella increased in reflux patients, while another found it depleted.31PubMed. Changes in the distal esophageal microbiota in Chinese patients with reflux esophagitis This is a field still in its early stages, where findings are suggestive but far from actionable. No microbiome-targeted therapy for reflux esophagitis exists yet, but the research points toward a future where the bacterial environment of the esophagus could become part of the clinical picture.